Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transgenic cell overlapped vascular inner rack and manufacture method thereof

A technology of transgenic cells and internal stents, applied in the field of intravascular stents, can solve the problems that cannot meet the requirements of planting

Inactive Publication Date: 2012-01-04
CHONGQING UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is clinically required that the simpler the operation of implanting endothelial cells and the shorter the time, the better. Therefore, primary vascular endothelial cells obtained from body veins alone cannot meet the requirements of implantation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transgenic cell overlapped vascular inner rack and manufacture method thereof
  • Transgenic cell overlapped vascular inner rack and manufacture method thereof
  • Transgenic cell overlapped vascular inner rack and manufacture method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] Below in conjunction with accompanying drawing, the present invention will be further described, but therefore the present invention is not limited among the scope of described embodiment:

[0036] see figure 1: The intravascular stent covered by the transgenic cells is provided with a treatment layer 1 on the metal surface of the traditional bare metal stent 4, an adhesion matrix coating 2 is arranged on the treatment layer 1, and a cell coating 3 is established on the adhesion matrix coating , Cell Coating 3 was obtained by stably transfecting cells with the gene of interest.

[0037] Wherein, the treatment layer 1 is a low-temperature plasma coating, and its surface roughness is 5-15 μm. Adhesion matrix coating 2 is one of protein coating and sequence peptide coating. The protein is one or more of proteins with the function of promoting cell adhesion, such as gelatin, type IV collagen, polylysine, and fibronectin. Sequence peptides are sequence peptides with the f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
surface roughnessaaaaaaaaaa
surface roughnessaaaaaaaaaa
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention provides an intravascular stent covered by transgene cells, which is characterized in that: a low-temperature plasma treatment layer, an adhesive interstitial substance coat and a cell coat are orderly arranged on the surface of the naked metal stent. The adhesive interstitial substance coat is a protein coat or a peptide sequence coat; the cell coat is obtained by stabilizing transfected cells by target gene. Preparing the intravascular stent includes the following steps: obtaining the target gene; constructing and amplifying the eukaryotic expression carrier of the target gene; obtaining cells; modifying the surface of the metal stent; preparing the adhesive interstitial substance coat; rotating, cultivating, and preparing the intravascular stent covered by transgene cells. On the one hand, by expressing the target gene at high-level, the rehabilitating of the injured endovascular endoderm is enhanced and the multiplication of smooth muscle cells is inhibited; one the other hand, by the multiplication of external-source cells, the surface endothelialization of the intravascular stent is accelerated; the coating is close applied on the surface of the stent, the biocompatibility is fine, and the intravascular stent can be inhibited from turning narrower ultimately.

Description

technical field [0001] The invention relates to a transgenic cell-covered intravascular stent, in particular to a transgenic cell-covered intravascular stent for inhibiting restenosis after percutaneous coronary angioplasty or stent implantation and a preparation method thereof. Background technique [0002] Intravascular restenosis is mainly due to mechanical damage (mainly endothelial layer damage) to the vessel wall caused by interventional surgery, which causes endothelial cell exfoliation and dysfunction, resulting in long-term exposure of the damaged part to the blood environment, inducing autoimmune stress and inflammatory response , inducing the migration and proliferation of monocytes in the blood and smooth muscle cells in the vascular media to the intima, and finally forming restenosis. Currently, restenosis has become a major challenge and research hotspot in vascular interventional therapy. [0003] Vascular endothelial cells are a class of cells with complex f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/11C12N15/79C12N15/861C12N5/10A61L31/10A61L31/12A61L31/02A61L31/14A61F2/82
Inventor 王贵学唐朝君吴雪邢才谢翔曹怡肖丽
Owner CHONGQING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products